Search our database and find Biotech companies in Netherlands based on your preferred criteria. Get key company details, track changes, and gain actionable insights to drive business growth or investment decisions.
Get to know our data at a glance with this sample company profile. We cover everything you need to know about Netherlands Biotech companies.
Available data points
Metadata
company_id
27897168
source_id
2599255
unique_domain
1
unique_website
1
last_updated_at
2025-04-01
created_at
2017-04-22
description
Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer™ RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/
type
Public Company
industry_group_1
Biotech
Firmographics
company_name
ProQR Therapeutics
company_legal_name
ProQR Therapeutics NV
industry
Biotechnology Research
founded_year
2012
size_range
51-200 employees
employees_count
179
Locations
hq_country
Netherlands
hq_country_iso2
NL
hq_country_iso3
NLD
hq_location
Leiden, Zuid-Holland, Netherlands
hq_full_address
*******
Follower counts & changes
followers_count_professional_network
14734
followers_count_owler
11
Financials
is_public
1
ipo_date
2014-09-19
ipo_share_price
13
ipo_share_price_currency
USD
Funding
last_funding_round_name
Post-IPO Equity - ProQR Therapeutics
last_funding_round_announced_date
2024-12-11
last_funding_round_amount_raised
8100000
last_funding_round_amount_raised_currency
$
last_funding_round_num_investors
1
Technographics
num_technologies_used
18
Company websites and social media
website
https://www.proqr.com
professional_network_url
https://www.professional-network.com/company/proqr-therapeutics-bv
financial_website_url
https://www.financial-website.com/organization/proqr-therapeutics
Website traffic
total_website_visits_monthly
10500
visits_change_monthly
42.22
rank_global
1966448
rank_country
784666
rank_category
800
bounce_rate
42.04
pages_per_visit
2.71
average_visit_duration_seconds
158
Employee review score & changes
company_employee_reviews_count
19
company_employee_reviews_aggregate_score
3.4
Workforce trends
active_job_postings_count
3
JSON data sample
{ "company_id": 27897168, "source_id": "2599255", "company_name": "ProQR Therapeutics", "company_name_alias": [ "proqr therapeutics", "proqr therapeutics n.v.", "proqr therapeutics nv" ], "company_legal_name": "ProQR Therapeutics NV", "company_logo": "/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsK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", "website": "https://www.proqr.com", "professional_network_url": "https://www.professional-network.com/company/proqr-therapeutics-bv", "twitter_url": [ "https://www.twitter.com/proqr" ], "discord_url": [], "facebook_url": [ "https://www.facebook.com/proqrtx" ], "instagram_url": [ "https://www.instagram.com/proqrtherapeutics" ], "pinterest_url": [], "tiktok_url": [], "youtube_url": [ "https://www.youtube.com/channel/ucc9p-avvx767-sfcxuveeaq" ], "github_url": [], "reddit_url": [], "financial_website_url": "https://www.financial-website.com/organization/proqr-therapeutics", "stock_ticker": [ { "exchange": null, "ticker": "PRQR" }, { "exchange": "NASDAQ", "ticker": "PRQR" } ], "is_b2b": 0, "industry": "Biotechnology Research", "sic_codes": [ "28", "283" ], "naics_codes": [ "32", "323" ], "categories_and_keywords": [ "biotechnology", "health > biotechnology and pharmaceuticals (in united states)", "rna editing", "rna therapeutics", "drug development", "rare diseases", "genetic diseases", "orphan drugs", "pharmaceuticals", "rna therapies", "biotech", "common diseases", "leiden", "health", "genetics", "pharma", "therapy", "health care", "therapeutics" ], "description": "Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer™ RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/", "description_enriched": "ProQR Therapeutics is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.", "description_metadata_raw": "ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.", "type": "Public Company", "status": { "value": "active", "comment": "Independent Company" }, "founded_year": "2012", "size_range": "51-200 employees", "employees_count": 179, "followers_count_professional_network": 14734, "followers_count_twitter": null, "followers_count_owler": 11, "hq_region": [ "Europe", "Western Europe", "EMEA", "EU" ], "hq_country": "Netherlands", "hq_country_iso2": "NL", "hq_country_iso3": "NLD", "hq_location": "Leiden, Zuid-Holland, Netherlands", "hq_full_address": "*******", "hq_city": null, "hq_state": null, "hq_street": null, "hq_zipcode": null, "company_locations_full": [ { "location_address": "*******", "is_primary": 1 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 } ], "is_public": 1, "ipo_date": "2014-09-19", "ipo_share_price": 13, "ipo_share_price_currency": "USD", "revenue_annual_range": { "source_4_annual_revenue_range": null, "source_6_annual_revenue_range": { "annual_revenue_range_from": 10000000, "annual_revenue_range_to": 15000000, "annual_revenue_range_currency": "$" } }, "revenue_annual": { "source_5_annual_revenue": { "annual_revenue": 14378222, "annual_revenue_currency": "$" }, "source_1_annual_revenue": { "annual_revenue": 6514000, "annual_revenue_currency": "€" } }, "revenue_quarterly": { "value": 3843000, "currency": "€" }, "income_statements": [ { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -9858000, "ebitda": -9618000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 499000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 859000, "interest_income": 0, "net_income": -10717000, "period_display_end_date": "Q1, 2018", "period_end_date": "2018-03-31", "period_type": "q1", "pre_tax_profit": -10717000, "revenue": 0, "total_operating_expense": 10117000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -7668000, "ebitda": -7425000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 971000, "gross_profit_margin": null, "income_tax_expense": 1000, "interest_expense": 0, "interest_income": 0, "net_income": -7400000, "period_display_end_date": "Q2, 2018", "period_end_date": "2018-06-30", "period_type": "q2", "pre_tax_profit": -7399000, "revenue": 0, "total_operating_expense": 8396000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -5918000, "ebitda": -5676000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 2958000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 74000, "interest_income": 0, "net_income": -5992000, "period_display_end_date": "Q3, 2018", "period_end_date": "2018-09-30", "period_type": "q3", "pre_tax_profit": -5992000, "revenue": 0, "total_operating_expense": 8634000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -36293000, "ebitda": -35301000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 5761000, "gross_profit_margin": null, "income_tax_expense": 1000, "interest_expense": 810000, "interest_income": 189000, "net_income": -37086000, "period_display_end_date": "FY, 2018", "period_end_date": "2018-12-31", "period_type": "fiscal_year", "pre_tax_profit": -37085000, "revenue": 0, "total_operating_expense": 41062000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -14738000, "ebitda": -14217000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 416000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 0, "interest_income": 0, "net_income": -14244000, "period_display_end_date": "Q1, 2019", "period_end_date": "2019-03-31", "period_type": "q1", "pre_tax_profit": -14244000, "revenue": 0, "total_operating_expense": 14633000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -11138000, "ebitda": -10622000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 563000, "gross_profit_margin": null, "income_tax_expense": 64000, "interest_expense": 531000, "interest_income": 0, "net_income": -11733000, "period_display_end_date": "Q2, 2019", "period_end_date": "2019-06-30", "period_type": "q2", "pre_tax_profit": -11669000, "revenue": 0, "total_operating_expense": 11883000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -13566000, "ebitda": -13060000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 530000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 0, "interest_income": 0, "net_income": -12191000, "period_display_end_date": "Q3, 2019", "period_end_date": "2019-09-30", "period_type": "q3", "pre_tax_profit": -12191000, "revenue": 0, "total_operating_expense": 13471000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -57016000, "ebitda": -54964000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 1933000, "gross_profit_margin": null, "income_tax_expense": 132000, "interest_expense": 1083000, "interest_income": 763000, "net_income": -56746000, "period_display_end_date": "FY, 2019", "period_end_date": "2019-12-31", "period_type": "fiscal_year", "pre_tax_profit": -56614000, "revenue": 0, "total_operating_expense": 57326000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -16614000, "ebitda": -16092000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 263000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 0, "interest_income": 0, "net_income": -16078000, "period_display_end_date": "Q1, 2020", "period_end_date": "2020-03-31", "period_type": "q1", "pre_tax_profit": -16078000, "revenue": 0, "total_operating_expense": 16221000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -3411000, "ebitda": -2881000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 8674000, "gross_profit_margin": null, "income_tax_expense": 11000, "interest_expense": 697000, "interest_income": 0, "net_income": -4119000, "period_display_end_date": "Q2, 2020", "period_end_date": "2020-06-30", "period_type": "q2", "pre_tax_profit": -4108000, "revenue": 0, "total_operating_expense": 11503000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -10946000, "ebitda": -10295000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 251000, "gross_profit_margin": null, "income_tax_expense": 75000, "interest_expense": 1863000, "interest_income": 0, "net_income": -13189000, "period_display_end_date": "Q3, 2020", "period_end_date": "2020-09-30", "period_type": "q3", "pre_tax_profit": -13114000, "revenue": 0, "total_operating_expense": 10462000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -42690000, "ebitda": -40335000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 9452000, "gross_profit_margin": null, "income_tax_expense": 124000, "interest_expense": 2124000, "interest_income": 313000, "net_income": -46614000, "period_display_end_date": "FY, 2020", "period_end_date": "2020-12-31", "period_type": "fiscal_year", "pre_tax_profit": -46490000, "revenue": 0, "total_operating_expense": 49465000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -12210000, "ebitda": -11579000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 141000, "gross_profit_margin": null, "income_tax_expense": 7000, "interest_expense": 293000, "interest_income": 0, "net_income": -12618000, "period_display_end_date": "Q1, 2021", "period_end_date": "2021-03-31", "period_type": "q1", "pre_tax_profit": -12611000, "revenue": 0, "total_operating_expense": 11613000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -13203000, "ebitda": -12601000, "ebitda_margin": -51.8559670781893, "ebit_margin": -54.333333333333336, "earnings_per_share": null, "gross_profit": 654000, "gross_profit_margin": 2.691358024691358, "income_tax_expense": 53000, "interest_expense": 2464000, "interest_income": 0, "net_income": -15753000, "period_display_end_date": "Q2, 2021", "period_end_date": "2021-06-30", "period_type": "q2", "pre_tax_profit": -15700000, "revenue": 243000, "total_operating_expense": 13255000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -14689000, "ebitda": -14145000, "ebitda_margin": -16.22133027522936, "ebit_margin": -16.845183486238533, "earnings_per_share": null, "gross_profit": 1158000, "gross_profit_margin": 1.3279816513761469, "income_tax_expense": 35000, "interest_expense": 0, "interest_income": 0, "net_income": -15069000, "period_display_end_date": "Q3, 2021", "period_end_date": "2021-09-30", "period_type": "q3", "pre_tax_profit": -15034000, "revenue": 872000, "total_operating_expense": 15171000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -56894000, "ebitda": -54565000, "ebitda_margin": -40.29911373707533, "ebit_margin": -42.019202363367796, "earnings_per_share": null, "gross_profit": 2397000, "gross_profit_margin": 1.7703101920236337, "income_tax_expense": 117000, "interest_expense": 3405000, "interest_income": 5000, "net_income": -61680000, "period_display_end_date": "FY, 2021", "period_end_date": "2021-12-31", "period_type": "fiscal_year", "pre_tax_profit": -61563000, "revenue": 1354000, "total_operating_expense": 57259000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -16948000, "ebitda": -16378000, "ebitda_margin": -13.272285251215559, "ebit_margin": -13.73419773095624, "earnings_per_share": null, "gross_profit": 1335000, "gross_profit_margin": 1.0818476499189627, "income_tax_expense": 7000, "interest_expense": 1259000, "interest_income": 0, "net_income": -14450000, "period_display_end_date": "Q1, 2022", "period_end_date": "2022-03-31", "period_type": "q1", "pre_tax_profit": -14443000, "revenue": 1234000, "total_operating_expense": 17705000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -15737000, "ebitda": -15146000, "ebitda_margin": -14.77658536585366, "ebit_margin": -15.353170731707317, "earnings_per_share": null, "gross_profit": 1124000, "gross_profit_margin": 1.0965853658536584, "income_tax_expense": 0, "interest_expense": 119000, "interest_income": 0, "net_income": -14670000, "period_display_end_date": "Q2, 2022", "period_end_date": "2022-06-30", "period_type": "q2", "pre_tax_profit": -14670000, "revenue": 1025000, "total_operating_expense": 16270000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -19681000, "ebitda": -19069000, "ebitda_margin": -19.946652719665273, "ebit_margin": -20.58682008368201, "earnings_per_share": null, "gross_profit": 1030000, "gross_profit_margin": 1.0774058577405858, "income_tax_expense": 69000, "interest_expense": 620000, "interest_income": 0, "net_income": -24381000, "period_display_end_date": "Q3, 2022", "period_end_date": "2022-09-30", "period_type": "q3", "pre_tax_profit": -24312000, "revenue": 956000, "total_operating_expense": 20099000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -64724000, "ebitda": -62203000, "ebitda_margin": -15.408223928659895, "ebit_margin": -16.032697547683924, "earnings_per_share": null, "gross_profit": 4802000, "gross_profit_margin": 1.1894971513500123, "income_tax_expense": 96000, "interest_expense": 5127000, "interest_income": 106000, "net_income": -64891000, "period_display_end_date": "FY, 2022", "period_end_date": "2022-12-31", "period_type": "fiscal_year", "pre_tax_profit": -64795000, "revenue": 4037000, "total_operating_expense": 66997000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -9389000, "ebitda": -8840000, "ebitda_margin": -13.49618320610687, "ebit_margin": -14.334351145038168, "earnings_per_share": null, "gross_profit": 697000, "gross_profit_margin": 1.0641221374045802, "income_tax_expense": 0, "interest_expense": 544000, "interest_income": 0, "net_income": -8855000, "period_display_end_date": "Q1, 2023", "period_end_date": "2023-03-31", "period_type": "q1", "pre_tax_profit": -8855000, "revenue": 655000, "total_operating_expense": 9537000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -8811000, "ebitda": -8217000, "ebitda_margin": -6.81908713692946, "ebit_margin": -7.312033195020747, "earnings_per_share": null, "gross_profit": 1243000, "gross_profit_margin": 1.0315352697095437, "income_tax_expense": -42000, "interest_expense": 0, "interest_income": 0, "net_income": -7977000, "period_display_end_date": "Q2, 2023", "period_end_date": "2023-06-30", "period_type": "q2", "pre_tax_profit": -8019000, "revenue": 1205000, "total_operating_expense": 9460000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -7299000, "ebitda": -6657000, "ebitda_margin": -4.8591240875912405, "ebit_margin": -5.327737226277372, "earnings_per_share": null, "gross_profit": 1370000, "gross_profit_margin": 1, "income_tax_expense": -41000, "interest_expense": -544000, "interest_income": 0, "net_income": -5420000, "period_display_end_date": "Q3, 2023", "period_end_date": "2023-09-30", "period_type": "q3", "pre_tax_profit": -5461000, "revenue": 1370000, "total_operating_expense": 8119000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -34698000, "ebitda": -32185000, "ebitda_margin": -4.940896530549585, "ebit_margin": -5.326680994780473, "earnings_per_share": null, "gross_profit": 6594000, "gross_profit_margin": 1.012281240405281, "income_tax_expense": -78000, "interest_expense": 1203000, "interest_income": 2593000, "net_income": -27735000, "period_display_end_date": "FY, 2023", "period_end_date": "2023-12-31", "period_type": "fiscal_year", "pre_tax_profit": -27813000, "revenue": 6514000, "total_operating_expense": 38871000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -8075000, "ebitda": -7384000, "ebitda_margin": -1.6593258426966293, "ebit_margin": -1.8146067415730338, "earnings_per_share": null, "gross_profit": 4660000, "gross_profit_margin": 1.047191011235955, "income_tax_expense": 3000, "interest_expense": 0, "interest_income": 0, "net_income": -7658000, "period_display_end_date": "Q1, 2024", "period_end_date": "2024-03-31", "period_type": "q1", "pre_tax_profit": -7655000, "revenue": 4450000, "total_operating_expense": 12044000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -3600000, "ebitda": -2889000, "ebitda_margin": -0.45820777160983345, "ebit_margin": -0.570975416336241, "earnings_per_share": null, "gross_profit": 6461000, "gross_profit_margin": 1.024742268041237, "income_tax_expense": -200000, "interest_expense": 0, "interest_income": 0, "net_income": -2692000, "period_display_end_date": "Q2, 2024", "period_end_date": "2024-06-30", "period_type": "q2", "pre_tax_profit": -2892000, "revenue": 6305000, "total_operating_expense": 9350000 }, { "cost_of_goods_sold": 0, "cost_of_goods_sold_currency": "€", "ebit": -8716000, "ebitda": -8028000, "ebitda_margin": -2.088992974238876, "ebit_margin": -2.2680197762164975, "earnings_per_share": null, "gross_profit": 3981000, "gross_profit_margin": 1.0359094457455114, "income_tax_expense": 0, "interest_expense": 0, "interest_income": 0, "net_income": -8108000, "period_display_end_date": "Q3, 2024", "period_end_date": "2024-09-30", "period_type": "q3", "pre_tax_profit": -8108000, "revenue": 3843000, "total_operating_expense": 12009000 } ], "stock_information": [ { "closing_price": 3.450000047683716, "currency": "$", "date": "2024-10-29", "marketcap": 281796704 }, { "closing_price": 0.777999997138977, "currency": "$", "date": "2022-06-30", "marketcap": 57325128 }, { "closing_price": 1.7400000095367432, "currency": "$", "date": "2023-05-31", "marketcap": 140828112 }, { "closing_price": 1.5, "currency": "$", "date": "2023-07-31", "marketcap": 121403544 }, { "closing_price": 2.759999990463257, "currency": "$", "date": "2023-01-31", "marketcap": 203442640 }, { "closing_price": 1.659999966621399, "currency": "$", "date": "2024-06-28", "marketcap": 135559248 }, { "closing_price": 2.180000066757202, "currency": "$", "date": "2023-04-27", "marketcap": 176181296 }, { "closing_price": 1.93, "currency": "$", "date": "2024-07-31", "marketcap": 157608046 }, { "closing_price": 1.940000057220459, "currency": "$", "date": "2024-04-30", "marketcap": 157827936 }, { "closing_price": 1.230000019073486, "currency": "$", "date": "2022-11-30", "marketcap": 90664656 }, { "closing_price": 3.700000047683716, "currency": "$", "date": "2022-12-30", "marketcap": 272731104 }, { "closing_price": 2.950000047683716, "currency": "$", "date": "2023-02-28", "marketcap": 210732080 }, { "closing_price": 2.289999961853027, "currency": "$", "date": "2024-03-28", "marketcap": 186293904 }, { "closing_price": 1.149999976158142, "currency": "$", "date": "2023-10-31", "marketcap": 93080768 }, { "closing_price": 1.950000047683715, "currency": "$", "date": "2024-05-31", "marketcap": 159063504 }, { "closing_price": 1.980000019073486, "currency": "$", "date": "2023-12-29", "marketcap": 160691856 }, { "closing_price": 0.9049999713897701, "currency": "$", "date": "2022-03-31", "marketcap": 66723292 }, { "closing_price": 1.820000052452087, "currency": "$", "date": "2024-09-30", "marketcap": 148657968 }, { "closing_price": 0.660000026226043, "currency": "$", "date": "2022-05-31", "marketcap": 48649332 }, { "closing_price": 1.070000052452087, "currency": "$", "date": "2022-02-28", "marketcap": 78870888 }, { "closing_price": 1.6200000047683711, "currency": "$", "date": "2023-06-30", "marketcap": 131115824 }, { "closing_price": 0.740000009536743, "currency": "$", "date": "2022-04-27", "marketcap": 54546216 }, { "closing_price": 0.790000021457672, "currency": "$", "date": "2022-08-31", "marketcap": 58224400 }, { "closing_price": 1.299999952316284, "currency": "$", "date": "2023-09-29", "marketcap": 105221736 }, { "closing_price": 5.449999809265137, "currency": "$", "date": "2022-01-31", "marketcap": 401725504 }, { "closing_price": 0.8379999995231621, "currency": "$", "date": "2022-07-29", "marketcap": 61740420 }, { "closing_price": 0.7440000176429741, "currency": "$", "date": "2022-09-30", "marketcap": 54841064 }, { "closing_price": 1.5499999523162842, "currency": "$", "date": "2023-11-30", "marketcap": 125794128 }, { "closing_price": 2.019999980926513, "currency": "$", "date": "2024-08-30", "marketcap": 164994000 }, { "closing_price": 2.015000104904175, "currency": "$", "date": "2024-02-29", "marketcap": 158490816 }, { "closing_price": 8.01, "currency": "$", "date": "2021-12-31", "marketcap": 410173298 }, { "closing_price": 1.6050000190734859, "currency": "$", "date": "2023-08-31", "marketcap": 129908384 }, { "closing_price": 2.170000076293945, "currency": "$", "date": "2024-01-31", "marketcap": 176111792 }, { "closing_price": 8.369999885559082, "currency": "$", "date": "2021-09-30", "marketcap": 553490496 }, { "closing_price": 0.9250000119209291, "currency": "$", "date": "2022-10-31", "marketcap": null }, { "closing_price": 2.130000114440918, "currency": "$", "date": "2023-03-31", "marketcap": 152155712 }, { "closing_price": 6.679999828338623, "currency": "$", "date": "2021-08-31", "marketcap": 441734368 }, { "closing_price": 7.8, "currency": "$", "date": "2021-11-12", "marketcap": 393103662 }, { "closing_price": 7.71999979019165, "currency": "$", "date": "2021-10-29", "marketcap": 517120192 } ], "last_funding_round_name": "Post-IPO Equity - ProQR Therapeutics", "last_funding_round_announced_date": "2024-12-11", "last_funding_round_lead_investors": [ "Rett Syndrome Research Trust" ], "last_funding_round_amount_raised": 8100000, "last_funding_round_amount_raised_currency": "$", "last_funding_round_num_investors": 1, "funding_rounds": [ { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2024-12-11", "lead_investors": [ "********" ], "amount_raised": 8100000, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2024-10-22", "lead_investors": [ "********" ], "amount_raised": 75000000, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Grant - ProQR Therapeutics", "announced_date": "2024-01-05", "lead_investors": [ "********" ], "amount_raised": 1000000, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2022-12-22", "lead_investors": [ "********" ], "amount_raised": null, "amount_raised_currency": null, "num_investors": 1 }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2021-03-30", "lead_investors": [], "amount_raised": 103500000, "amount_raised_currency": "$", "num_investors": null }, { "name": "Post-IPO Debt - ProQR Therapeutics", "announced_date": "2020-07-14", "lead_investors": [ "********" ], "amount_raised": 30000000, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2019-10-15", "lead_investors": [], "amount_raised": 57500000, "amount_raised_currency": "$", "num_investors": null }, { "name": "Post-IPO Debt - ProQR Therapeutics", "announced_date": "2018-12-10", "lead_investors": [], "amount_raised": 5337337, "amount_raised_currency": "$", "num_investors": null }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2018-09-05", "lead_investors": [], "amount_raised": 104100000, "amount_raised_currency": "$", "num_investors": null }, { "name": "Series A - ProQR Therapeutics", "announced_date": "2014-04-01", "lead_investors": [ "********" ], "amount_raised": 57933671, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - ProQR Therapeutics", "announced_date": "2022-12-26", "lead_investors": [ "********" ], "amount_raised": null, "amount_raised_currency": null, "num_investors": 1 }, { "name": "Seed Round - ProQR Therapeutics", "announced_date": "2013-01-01", "lead_investors": [], "amount_raised": null, "amount_raised_currency": null, "num_investors": 1 } ], "ownership_status": "Public", "parent_company_information": null, "acquired_by_summary": null, "num_acquisitions_source_1": null, "acquisition_list_source_1": [], "num_acquisitions_source_2": null, "acquisition_list_source_2": [], "num_acquisitions_source_5": null, "acquisition_list_source_5": [], "competitors": [ { "company_name": "precigen", "similarity_score": null }, { "company_name": "regulus", "similarity_score": 22198 }, { "company_name": "editas medicine", "similarity_score": 22199 }, { "company_name": "interna", "similarity_score": 100000 }, { "company_name": "cell therapies", "similarity_score": null }, { "company_name": "asklepios biopharmaceutical", "similarity_score": null }, { "company_name": "graphite bio", "similarity_score": null }, { "company_name": "alnylam", "similarity_score": 22200 } ], "competitors_websites": [ { "website": "rtwfunds.com", "similarity_score": 100, "total_website_visits_monthly": 6800, "category": "Health > Biotechnology and Pharmaceuticals", "rank_category": 3249 }, { "website": "sofinnovapartners.com", "similarity_score": 100, "total_website_visits_monthly": 12800, "category": "Health > Biotechnology and Pharmaceuticals", "rank_category": 2544 } ], "company_phone_numbers": [ "********", "********" ], "company_emails": [ "****@proqr.com" ], "pricing_available": 0, "free_trial_available": 0, "demo_available": 0, "is_downloadable": 0, "mobile_apps_exist": 0, "online_reviews_exist": 0, "documentation_exist": 0, "product_reviews_count": null, "product_reviews_aggregate_score": null, "product_reviews_score_distribution": null, "product_pricing_summary": [], "num_news_articles": 0, "news_articles": [], "num_technologies_used": 18, "technologies_used": [ { "technology": "python", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "c", "first_verified_at": "2024-09-30", "last_verified_at": "2025-03-31" }, { "technology": "java", "first_verified_at": "2024-07-15", "last_verified_at": "2025-03-31" }, { "technology": "microsoft", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "medium", "first_verified_at": "2024-04-04", "last_verified_at": "2025-01-27" }, { "technology": "git", "first_verified_at": "2024-05-06", "last_verified_at": "2025-03-31" }, { "technology": "scikit-learn", "first_verified_at": "2024-04-04", "last_verified_at": "2025-02-10" }, { "technology": "well", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "visa", "first_verified_at": "2024-04-04", "last_verified_at": "2024-07-15" }, { "technology": "mysql", "first_verified_at": "2024-04-04", "last_verified_at": "2024-04-29" }, { "technology": "4me", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "impact", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "adp", "first_verified_at": "2024-04-04", "last_verified_at": "2024-07-15" }, { "technology": "amp", "first_verified_at": "2024-05-20", "last_verified_at": "2025-03-31" }, { "technology": "unix", "first_verified_at": "2024-04-04", "last_verified_at": "2024-04-29" }, { "technology": "linux", "first_verified_at": "2024-05-06", "last_verified_at": "2025-03-31" }, { "technology": "teamtailor", "first_verified_at": "2024-04-04", "last_verified_at": "2024-07-15" }, { "technology": "sap concur", "first_verified_at": "2024-05-20", "last_verified_at": "2025-03-31" } ], "total_website_visits_monthly": 10500, "visits_change_monthly": 42.22, "rank_global": 1966448, "rank_country": 784666, "rank_category": 800, "visits_breakdown_by_country": [], "visits_breakdown_by_gender": { "male_percentage": 0, "female_percentage": 0 }, "visits_breakdown_by_age": { "age_18_24_percentage": 0, "age_25_34_percentage": 0, "age_35_44_percentage": 0, "age_45_54_percentage": 0, "age_55_64_percentage": 0, "age_65_plus_percentage": 0 }, "bounce_rate": 42.04, "pages_per_visit": 2.71, "average_visit_duration_seconds": 158, "similarly_ranked_websites": [ "mt-pharma-america.com", "x4pharma.com", "proqr.com", "fplcalculator.com", "kaken.co.jp", "sofinnovapartners.com", "proqr.com", "rtwfunds.com" ], "top_topics": [ "internet video", "social network", "videos", "web video", "youtube videos" ], "company_employee_reviews_count": 19, "company_employee_reviews_aggregate_score": 3.4, "employee_reviews_score_breakdown": { "business_outlook": 0.31, "career_opportunities": 3.4, "ceo_approval": -1, "compensation_benefits": 3.7, "culture_values": 3.3, "diversity_inclusion": 4.1, "recommend": 0.61, "senior_management": 2.7, "work_life_balance": 3.6 }, "employee_reviews_score_distribution": { "1": 2, "2": 3, "3": 0, "4": 2, "5": 2 }, "active_job_postings_count": 3, "active_job_postings_titles": [ "Team Manager R&D", "DP Manufacturing Lead", "Senior Scientist Process Chemistry" ], "base_salary": [], "additional_pay": [], "total_salary": [], "employees_count_breakdown_by_seniority": { "employees_count_owner": 0, "employees_count_founder": 1, "employees_count_clevel": 3, "employees_count_partner": 2, "employees_count_vp": 1, "employees_count_head": 0, "employees_count_director": 11, "employees_count_manager": 3, "employees_count_senior": 24, "employees_count_intern": 0, "employees_count_specialist": 79, "employees_count_other_management": 29 }, "employees_count_breakdown_by_department": { "employees_count_medical": 2, "employees_count_sales": 1, "employees_count_hr": 3, "employees_count_legal": 3, "employees_count_marketing": 1, "employees_count_finance": 6, "employees_count_technical": 1, "employees_count_consulting": 0, "employees_count_operations": 2, "employees_count_product": 1, "employees_count_general_management": 8, "employees_count_administrative": 5, "employees_count_customer_service": 2, "employees_count_project_management": 2, "employees_count_design": 1, "employees_count_research": 77, "employees_count_trades": 0, "employees_count_real_estate": 0, "employees_count_education": 0, "employees_count_other_department": 38 }, "employees_count_breakdown_by_region": { "employees_count_eastern_europe": 0, "employees_count_latin_america": 0, "employees_count_southern_europe": 1, "employees_count_sub_saharan_africa": 0, "employees_count_central_asia": 0, "employees_count_northern_america": 3, "employees_count_australia_new_zealand": 0, "employees_count_northern_europe": 2, "employees_count_south_eastern_asia": 0, "employees_count_polynesia": 0, "employees_count_southern_asia": 0, "employees_count_northern_africa": 0, "employees_count_melanesia": 0, "employees_count_western_europe": 147, "employees_count_western_asia": 0, "employees_count_eastern_asia": 0, "employees_count_micronesia": 0, "employees_count_unknown": 0 }, "employees_count_by_country": [ { "country": "United Kingdom", "employee_count": 2 }, { "country": "Spain", "employee_count": 1 }, { "country": "Netherlands", "employee_count": 146 }, { "country": "Belgium", "employee_count": 1 }, { "country": "United States", "employee_count": 3 } ], "key_executives": [ { "member_id": 336203375, "member_full_name": "*******", "member_position_title": "Director" }, { "member_id": 348182239, "member_full_name": "*******", "member_position_title": "Chief People Operations Officer" }, { "member_id": 89604614, "member_full_name": "*******", "member_position_title": "FPA Director" }, { "member_id": 132214792, "member_full_name": "*******", "member_position_title": "Principal Scientific Advisor RNA Modulation" }, { "member_id": 275918256, "member_full_name": "*******", "member_position_title": "Director Scientific Affairs - Strategy And Communications" }, { "member_id": 207915366, "member_full_name": "*******", "member_position_title": "Associate Director" }, { "member_id": 328532399, "member_full_name": "*******", "member_position_title": "VP, Head Of Development" }, { "member_id": 111695003, "member_full_name": "*******", "member_position_title": "Vice President - Chief Of Staff To The CEO" }, { "member_id": 235370788, "member_full_name": "*******", "member_position_title": "HR Business Partner" }, { "member_id": 303213564, "member_full_name": "*******", "member_position_title": "Associate Director Nonclinical Pharmacology" }, { "member_id": 263940244, "member_full_name": "*******", "member_position_title": "Director Of Corporate Communications" }, { "member_id": 441629253, "member_full_name": "*******", "member_position_title": "Associate Director IP" }, { "member_id": 762994437, "member_full_name": "*******", "member_position_title": "Sr Director Of Procurement" }, { "member_id": 115299115, "member_full_name": "*******", "member_position_title": "Board Member" }, { "member_id": 232788345, "member_full_name": "*******", "member_position_title": "Executive Assistant To Chief Scientific Officer" }, { "member_id": 341438030, "member_full_name": "*******", "member_position_title": "Interim IT Director" }, { "member_id": 8670110, "member_full_name": "*******", "member_position_title": "Principal Researcher" }, { "member_id": 444357525, "member_full_name": "*******", "member_position_title": "Director Project Management" }, { "member_id": 80761235, "member_full_name": "*******", "member_position_title": "Principal Scientist" }, { "member_id": 87143158, "member_full_name": "*******", "member_position_title": "Assistant Director Of Human Resources" }, { "member_id": 89450522, "member_full_name": "*******", "member_position_title": "Head Of IP" }, { "member_id": 24684061, "member_full_name": "*******", "member_position_title": "Sr Director Platform Development" }, { "member_id": 117531374, "member_full_name": "*******", "member_position_title": "VP Scientific Operations" }, { "member_id": 344614749, "member_full_name": "*******", "member_position_title": "Principal Researcher" }, { "member_id": 609932094, "member_full_name": "*******", "member_position_title": "Director Finance" }, { "member_id": 286473434, "member_full_name": "*******", "member_position_title": "Chief Corporate Development Officer General Counsel" }, { "member_id": 269638500, "member_full_name": "*******", "member_position_title": "Director Toxicology DMPK At ProQR Therapeutics" } ], "key_employee_change_events": [], "key_executive_arrivals": [ { "member_id": 80761235, "member_full_name": "*******", "member_position_title": "Principal Scientist", "arrival_date": "Mar 2025" } ], "key_executive_departures": [ { "member_id": 322992617, "member_full_name": "*******", "member_position_title": "Sr. Director", "departure_date": "Jan 2025" } ], "employees_count_change": { "current": 179, "change_monthly": -2, "change_monthly_percentage": -1.1049723756906076, "change_quarterly": 0, "change_quarterly_percentage": 0, "change_yearly": 14, "change_yearly_percentage": 8.484848484848486 }, "employees_count_by_month": [ { "employees_count": 163, "date": "2021-05" }, { "employees_count": 179, "date": "2025-04" }, { "employees_count": 169, "date": "2024-05" }, { "employees_count": 172, "date": "2024-08" }, { "employees_count": 148, "date": "2023-06" }, { "employees_count": 162, "date": "2021-04" }, { "employees_count": 179, "date": "2025-01" }, { "employees_count": 207, "date": "2022-05" }, { "employees_count": 180, "date": "2022-09" }, { "employees_count": 170, "date": "2023-12" }, { "employees_count": 163, "date": "2023-11" }, { "employees_count": 182, "date": "2021-12" }, { "employees_count": 166, "date": "2024-02" }, { "employees_count": 167, "date": "2021-09" }, { "employees_count": 173, "date": "2024-07" }, { "employees_count": 167, "date": "2021-08" }, { "employees_count": 162, "date": "2023-09" }, { "employees_count": 176, "date": "2024-11" }, { "employees_count": 166, "date": "2021-03" }, { "employees_count": 195, "date": "2022-07" }, { "employees_count": 161, "date": "2021-01" }, { "employees_count": 199, "date": "2022-06" }, { "employees_count": 167, "date": "2020-10" }, { "employees_count": 149, "date": "2023-02" }, { "employees_count": 181, "date": "2025-03" }, { "employees_count": 206, "date": "2022-04" }, { "employees_count": 138, "date": "2023-03" }, { "employees_count": 172, "date": "2020-07" }, { "employees_count": 182, "date": "2025-02" }, { "employees_count": 170, "date": "2020-09" }, { "employees_count": 184, "date": "2022-01" }, { "employees_count": 180, "date": "2022-08" }, { "employees_count": 137, "date": "2023-05" }, { "employees_count": 172, "date": "2020-06" }, { "employees_count": 172, "date": "2021-10" }, { "employees_count": 168, "date": "2021-07" }, { "employees_count": 175, "date": "2021-11" }, { "employees_count": 178, "date": "2024-12" }, { "employees_count": 161, "date": "2021-06" }, { "employees_count": 165, "date": "2024-04" }, { "employees_count": 169, "date": "2024-06" }, { "employees_count": 161, "date": "2021-02" }, { "employees_count": 139, "date": "2023-04" }, { "employees_count": 167, "date": "2022-10" }, { "employees_count": 173, "date": "2024-09" }, { "employees_count": 0, "date": "2020-08" }, { "employees_count": 168, "date": "2022-11" }, { "employees_count": 168, "date": "2024-03" }, { "employees_count": 174, "date": "2024-10" }, { "employees_count": 202, "date": "2022-03" }, { "employees_count": 152, "date": "2023-01" }, { "employees_count": 167, "date": "2024-01" }, { "employees_count": 161, "date": "2020-12" }, { "employees_count": 167, "date": "2020-11" }, { "employees_count": 159, "date": "2023-08" }, { "employees_count": 156, "date": "2023-07" }, { "employees_count": 157, "date": "2022-12" }, { "employees_count": 188, "date": "2022-02" }, { "employees_count": 164, "date": "2023-10" } ], "professional_network_followers_count_change": { "current": 14734, "change_monthly": 144, "change_monthly_percentage": 0.9869773817683345, "change_quarterly": 617, "change_quarterly_percentage": 4.3706169866118865, "change_yearly": 2251, "change_yearly_percentage": 18.03252423295682 }, "professional_network_followers_count_by_month": [ { "follower_count": 6563, "date": "2022-04" }, { "follower_count": 14734, "date": "2025-04" }, { "follower_count": 13146, "date": "2024-08" }, { "follower_count": 4775, "date": "2021-04" }, { "follower_count": 6697, "date": "2022-05" }, { "follower_count": 7665, "date": "2022-09" }, { "follower_count": 11512, "date": "2023-12" }, { "follower_count": 9551, "date": "2023-03" }, { "follower_count": 5880, "date": "2021-11" }, { "follower_count": 13658, "date": "2024-11" }, { "follower_count": 4702, "date": "2021-03" }, { "follower_count": 4507, "date": "2021-02" }, { "follower_count": 5198, "date": "2021-06" }, { "follower_count": 4425, "date": "2021-01" }, { "follower_count": 12483, "date": "2024-04" }, { "follower_count": 4162, "date": "2020-10" }, { "follower_count": 9245, "date": "2023-02" }, { "follower_count": 12846, "date": "2024-06" }, { "follower_count": 9743, "date": "2023-04" }, { "follower_count": 8221, "date": "2022-10" }, { "follower_count": 13250, "date": "2024-09" }, { "follower_count": 5481, "date": "2021-09" }, { "follower_count": 12966, "date": "2024-07" }, { "follower_count": 4024, "date": "2020-08" }, { "follower_count": 8415, "date": "2022-11" }, { "follower_count": 12337, "date": "2024-03" }, { "follower_count": 13413, "date": "2024-10" }, { "follower_count": 14590, "date": "2025-03" }, { "follower_count": 3821, "date": "2020-07" }, { "follower_count": 11271, "date": "2023-11" }, { "follower_count": 6048, "date": "2021-12" }, { "follower_count": 5429, "date": "2021-08" }, { "follower_count": 10826, "date": "2023-09" }, { "follower_count": 13985, "date": "2024-12" }, { "follower_count": 14354, "date": "2025-02" }, { "follower_count": 4258, "date": "2020-11" }, { "follower_count": 10582, "date": "2023-08" }, { "follower_count": 10395, "date": "2023-07" }, { "follower_count": 8925, "date": "2022-12" }, { "follower_count": 6397, "date": "2022-03" }, { "follower_count": 9136, "date": "2023-01" }, { "follower_count": 11724, "date": "2024-01" }, { "follower_count": 4407, "date": "2020-12" }, { "follower_count": 11052, "date": "2023-10" }, { "follower_count": 5711, "date": "2021-10" }, { "follower_count": 7422, "date": "2022-07" }, { "follower_count": 5314, "date": "2021-07" }, { "follower_count": 4102, "date": "2020-09" }, { "follower_count": 6127, "date": "2022-01" }, { "follower_count": 7665, "date": "2022-08" }, { "follower_count": 9989, "date": "2023-05" }, { "follower_count": 3813, "date": "2020-06" }, { "follower_count": 12059, "date": "2024-02" }, { "follower_count": 6183, "date": "2022-02" }, { "follower_count": 5141, "date": "2021-05" }, { "follower_count": 12625, "date": "2024-05" }, { "follower_count": 10111, "date": "2023-06" }, { "follower_count": 14117, "date": "2025-01" }, { "follower_count": 7229, "date": "2022-06" } ], "active_job_postings_count_change": { "current": 3, "change_monthly": -1, "change_monthly_percentage": -25, "change_quarterly": 0, "change_quarterly_percentage": 0, "change_yearly": -9, "change_yearly_percentage": -75 }, "product_reviews_score_change": null, "product_reviews_score_by_month": [], "total_website_visits_change": { "current": 7400, "change_monthly": -2200, "change_monthly_percentage": -22.916666666666664, "change_quarterly": -11000, "change_quarterly_percentage": -59.78260869565217, "change_yearly": -33400, "change_yearly_percentage": -81.86274509803921 }, "total_website_visits_by_month": [ { "total_website_visits": 9600, "date": "2025-03" }, { "total_website_visits": 23500, "date": "2024-08" }, { "total_website_visits": 23500, "date": "2024-07" }, { "total_website_visits": 23500, "date": "2024-10" }, { "total_website_visits": 7400, "date": "2025-04" }, { "total_website_visits": 18400, "date": "2025-02" }, { "total_website_visits": 23500, "date": "2024-09" }, { "total_website_visits": 18400, "date": "2025-01" }, { "total_website_visits": 12600, "date": "2024-11" }, { "total_website_visits": 23500, "date": "2024-05" }, { "total_website_visits": 40800, "date": "2024-04" }, { "total_website_visits": 27400, "date": "2024-12" }, { "total_website_visits": 23500, "date": "2024-06" } ], "employee_reviews_score_aggregated_change": { "current": 3.4, "change_monthly": 0, "change_quarterly": -0.10000000000000009, "change_yearly": null }, "employee_reviews_score_aggregated_by_month": [ { "aggregated_score": 3.4, "date": "2025-03" }, { "aggregated_score": 3.5, "date": "2024-02" }, { "aggregated_score": 3.5, "date": "2025-01" }, { "aggregated_score": 3.6, "date": "2024-03" }, { "aggregated_score": 3.7, "date": "2023-11" }, { "aggregated_score": 3.6, "date": "2024-05" }, { "aggregated_score": 3.6, "date": "2024-04" }, { "aggregated_score": 3.4, "date": "2024-08" }, { "aggregated_score": 3.4, "date": "2024-07" }, { "aggregated_score": 3.4, "date": "2024-09" }, { "aggregated_score": 3.5, "date": "2023-12" }, { "aggregated_score": 3.5, "date": "2024-01" }, { "aggregated_score": 3.5, "date": "2025-02" }, { "aggregated_score": 3.3, "date": "2024-11" }, { "aggregated_score": 3.5, "date": "2024-12" }, { "aggregated_score": 3.4, "date": "2025-04" }, { "aggregated_score": 3.6, "date": "2024-06" } ], "employee_reviews_score_business_outlook_change": { "current": 0.31, "change_monthly": 0.06, "change_quarterly": 0.09, "change_yearly": null }, "employee_reviews_score_business_outlook_by_month": [ { "business_outlook_score": 0.25, "date": "2025-03" }, { "business_outlook_score": 0.13, "date": "2024-03" }, { "business_outlook_score": 0.13, "date": "2024-02" }, { "business_outlook_score": 0.13, "date": "2024-05" }, { "business_outlook_score": 0.13, "date": "2024-04" }, { "business_outlook_score": 0.11, "date": "2024-07" }, { "business_outlook_score": 0.22, "date": "2025-01" }, { "business_outlook_score": 0.15, "date": "2023-11" }, { "business_outlook_score": 0.11, "date": "2024-11" }, { "business_outlook_score": 0.13, "date": "2023-12" }, { "business_outlook_score": 0.13, "date": "2024-01" }, { "business_outlook_score": 0.11, "date": "2024-08" }, { "business_outlook_score": 0.22, "date": "2024-12" }, { "business_outlook_score": 0.22, "date": "2025-02" }, { "business_outlook_score": 0.31, "date": "2025-04" }, { "business_outlook_score": 0.11, "date": "2024-09" }, { "business_outlook_score": 0.13, "date": "2024-06" } ], "employee_reviews_score_career_opportunities_change": { "current": 3.4, "change_monthly": -0.10000000000000009, "change_quarterly": -0.20000000000000018, "change_yearly": null }, "employee_reviews_score_career_opportunities_by_month": [ { "career_opportunities_score": 3.7, "date": "2024-02" }, { "career_opportunities_score": 3.7, "date": "2024-05" }, { "career_opportunities_score": 3.7, "date": "2024-04" }, { "career_opportunities_score": 3.6, "date": "2025-01" }, { "career_opportunities_score": 3.5, "date": "2025-03" }, { "career_opportunities_score": 3.4, "date": "2024-07" }, { "career_opportunities_score": 3.7, "date": "2023-12" }, { "career_opportunities_score": 3.7, "date": "2024-01" }, { "career_opportunities_score": 3.8, "date": "2023-11" }, { "career_opportunities_score": 3.6, "date": "2025-02" }, { "career_opportunities_score": 3.4, "date": "2024-08" }, { "career_opportunities_score": 3.6, "date": "2024-12" }, { "career_opportunities_score": 3.4, "date": "2025-04" }, { "career_opportunities_score": 3.4, "date": "2024-09" }, { "career_opportunities_score": 3.7, "date": "2024-03" }, { "career_opportunities_score": 3.4, "date": "2024-11" }, { "career_opportunities_score": 3.7, "date": "2024-06" } ], "employee_reviews_score_ceo_approval_change": { "current": -1, "change_monthly": 0, "change_quarterly": -1, "change_yearly": null }, "employee_reviews_score_ceo_approval_by_month": [ { "ceo_approval_score": 0, "date": "2024-11" }, { "ceo_approval_score": 0, "date": "2025-01" }, { "ceo_approval_score": 0, "date": "2023-12" }, { "ceo_approval_score": 0, "date": "2024-01" }, { "ceo_approval_score": 0, "date": "2024-12" }, { "ceo_approval_score": -1, "date": "2025-03" }, { "ceo_approval_score": 0, "date": "2024-08" }, { "ceo_approval_score": -1, "date": "2025-04" }, { "ceo_approval_score": 0, "date": "2024-03" }, { "ceo_approval_score": 0, "date": "2024-05" }, { "ceo_approval_score": 0, "date": "2024-04" }, { "ceo_approval_score": 0, "date": "2023-11" }, { "ceo_approval_score": 0, "date": "2024-02" }, { "ceo_approval_score": 0, "date": "2024-07" }, { "ceo_approval_score": 0, "date": "2025-02" }, { "ceo_approval_score": 0, "date": "2024-09" }, { "ceo_approval_score": 0, "date": "2024-06" } ], "employee_reviews_score_compensation_benefits_change": { "current": 3.7, "change_monthly": -0.09999999999999964, "change_quarterly": -0.09999999999999964, "change_yearly": null }, "employee_reviews_score_compensation_benefits_by_month": [ { "compensation_benefits_score": 3.9, "date": "2023-12" }, { "compensation_benefits_score": 3.9, "date": "2024-01" }, { "compensation_benefits_score": 3.9, "date": "2024-03" }, { "compensation_benefits_score": 3.8, "date": "2025-02" }, { "compensation_benefits_score": 3.8, "date": "2024-07" }, { "compensation_benefits_score": 3.6, "date": "2024-11" }, { "compensation_benefits_score": 3.8, "date": "2025-01" }, { "compensation_benefits_score": 3.8, "date": "2024-12" }, { "compensation_benefits_score": 3.9, "date": "2024-02" }, { "compensation_benefits_score": 3.8, "date": "2025-03" }, { "compensation_benefits_score": 3.7, "date": "2025-04" }, { "compensation_benefits_score": 3.8, "date": "2023-11" }, { "compensation_benefits_score": 3.8, "date": "2024-08" }, { "compensation_benefits_score": 3.9, "date": "2024-05" }, { "compensation_benefits_score": 3.9, "date": "2024-04" }, { "compensation_benefits_score": 3.8, "date": "2024-09" }, { "compensation_benefits_score": 3.9, "date": "2024-06" } ], "employee_reviews_score_culture_values_change": { "current": 3.3, "change_monthly": -0.20000000000000018, "change_quarterly": -0.20000000000000018, "change_yearly": null }, "employee_reviews_score_culture_values_by_month": [ { "culture_values_score": 3.3, "date": "2025-04" }, { "culture_values_score": 3.4, "date": "2024-07" }, { "culture_values_score": 3.5, "date": "2025-03" }, { "culture_values_score": 3.5, "date": "2025-01" }, { "culture_values_score": 3.5, "date": "2024-12" }, { "culture_values_score": 3.3, "date": "2024-11" }, { "culture_values_score": 3.7, "date": "2024-05" }, { "culture_values_score": 3.7, "date": "2024-04" }, { "culture_values_score": 3.7, "date": "2023-12" }, { "culture_values_score": 3.7, "date": "2024-01" }, { "culture_values_score": 3.7, "date": "2024-02" }, { "culture_values_score": 3.4, "date": "2024-09" }, { "culture_values_score": 3.7, "date": "2024-03" }, { "culture_values_score": 3.9, "date": "2023-11" }, { "culture_values_score": 3.7, "date": "2024-06" }, { "culture_values_score": 3.4, "date": "2024-08" }, { "culture_values_score": 3.5, "date": "2025-02" } ], "employee_reviews_score_diversity_inclusion_change": { "current": 4.1, "change_monthly": -0.10000000000000053, "change_quarterly": -0.20000000000000018, "change_yearly": null }, "employee_reviews_score_diversity_inclusion_by_month": [ { "diversity_inclusion_score": 4.3, "date": "2024-08" }, { "diversity_inclusion_score": 4.3, "date": "2024-07" }, { "diversity_inclusion_score": 4.3, "date": "2025-01" }, { "diversity_inclusion_score": 4.2, "date": "2023-11" }, { "diversity_inclusion_score": 4.3, "date": "2025-02" }, { "diversity_inclusion_score": 4.2, "date": "2025-03" }, { "diversity_inclusion_score": 4.2, "date": "2024-02" }, { "diversity_inclusion_score": 4.2, "date": "2023-12" }, { "diversity_inclusion_score": 4.2, "date": "2024-01" }, { "diversity_inclusion_score": 4.2, "date": "2024-03" }, { "diversity_inclusion_score": 4.2, "date": "2024-11" }, { "diversity_inclusion_score": 4.2, "date": "2024-05" }, { "diversity_inclusion_score": 4.2, "date": "2024-04" }, { "diversity_inclusion_score": 4.3, "date": "2024-12" }, { "diversity_inclusion_score": 4.3, "date": "2024-09" }, { "diversity_inclusion_score": 4.1, "date": "2025-04" }, { "diversity_inclusion_score": 4.2, "date": "2024-06" } ], "employee_reviews_score_recommend_change": { "current": 0.61, "change_monthly": -0.030000000000000027, "change_quarterly": -0.040000000000000036, "change_yearly": null }, "employee_reviews_score_recommend_by_month": [ { "recommend_score": 0.75, "date": "2024-06" }, { "recommend_score": 0.59, "date": "2024-11" }, { "recommend_score": 0.64, "date": "2025-03" }, { "recommend_score": 0.65, "date": "2025-01" }, { "recommend_score": 0.75, "date": "2024-03" }, { "recommend_score": 0.75, "date": "2024-05" }, { "recommend_score": 0.75, "date": "2024-04" }, { "recommend_score": 0.64, "date": "2024-09" }, { "recommend_score": 0.65, "date": "2024-12" }, { "recommend_score": 0.64, "date": "2024-07" }, { "recommend_score": 0.75, "date": "2023-12" }, { "recommend_score": 0.75, "date": "2024-01" }, { "recommend_score": 0.65, "date": "2025-02" }, { "recommend_score": 0.75, "date": "2024-02" }, { "recommend_score": 0.75, "date": "2023-11" }, { "recommend_score": 0.64, "date": "2024-08" }, { "recommend_score": 0.61, "date": "2025-04" } ], "employee_reviews_score_senior_management_change": { "current": 2.7, "change_monthly": -0.09999999999999964, "change_quarterly": -0.19999999999999973, "change_yearly": null }, "employee_reviews_score_senior_management_by_month": [ { "senior_management_score": 2.8, "date": "2025-03" }, { "senior_management_score": 2.9, "date": "2024-07" }, { "senior_management_score": 2.7, "date": "2025-04" }, { "senior_management_score": 3.3, "date": "2023-11" }, { "senior_management_score": 3.1, "date": "2024-05" }, { "senior_management_score": 3.1, "date": "2024-04" }, { "senior_management_score": 3.1, "date": "2024-02" }, { "senior_management_score": 2.9, "date": "2024-08" }, { "senior_management_score": 3.1, "date": "2024-03" }, { "senior_management_score": 2.9, "date": "2024-09" }, { "senior_management_score": 2.9, "date": "2025-01" }, { "senior_management_score": 3.1, "date": "2024-06" }, { "senior_management_score": 2.7, "date": "2024-11" }, { "senior_management_score": 3.1, "date": "2023-12" }, { "senior_management_score": 3.1, "date": "2024-01" }, { "senior_management_score": 2.9, "date": "2025-02" }, { "senior_management_score": 2.9, "date": "2024-12" } ], "employee_reviews_score_work_life_balance_change": { "current": 3.6, "change_monthly": -0.10000000000000009, "change_quarterly": -0.19999999999999973, "change_yearly": null }, "employee_reviews_score_work_life_balance_by_month": [ { "work_life_balance_score": 4, "date": "2024-05" }, { "work_life_balance_score": 4, "date": "2024-04" }, { "work_life_balance_score": 3.8, "date": "2024-07" }, { "work_life_balance_score": 4, "date": "2024-06" }, { "work_life_balance_score": 3.7, "date": "2025-03" }, { "work_life_balance_score": 3.7, "date": "2024-11" }, { "work_life_balance_score": 3.8, "date": "2025-01" }, { "work_life_balance_score": 4, "date": "2023-12" }, { "work_life_balance_score": 4, "date": "2024-01" }, { "work_life_balance_score": 4.1, "date": "2023-11" }, { "work_life_balance_score": 4, "date": "2024-02" }, { "work_life_balance_score": 3.8, "date": "2024-08" }, { "work_life_balance_score": 4, "date": "2024-03" }, { "work_life_balance_score": 3.8, "date": "2025-02" }, { "work_life_balance_score": 3.8, "date": "2024-09" }, { "work_life_balance_score": 3.8, "date": "2024-12" }, { "work_life_balance_score": 3.6, "date": "2025-04" } ], "expired_domain": 0, "unique_domain": 1, "unique_website": 1, "last_updated_at": "2025-04-01", "created_at": "2017-04-22", "industry_group_1": "Biotech", "industry_group_2": null }
Your data must have high quality if you want to turn it into valuable insights. Arm yourself with the latest intel that will paint the big picture about emerging Biotech industry trends and tell you granular, company-level stories.
Each Netherlands Biotech company profile, collected and enriched by Coresignal, includes:
Combined, these data points create the most comprehensive Biotech companies in Netherlands database. With 500+ data points for analysis, you can be sure to find the answer to any question about the industry.
Access data as comprehensive dataset files or via an API
Boost your existing dataset with the no-code data enrichment tool
Find competitors and similar companies
Track headcount changes
Review Netherlands historical company data
200 free collect and 400 search credits
Unlock the Netherlands Biotech sector with Coresignal's extensive datasets and data APIs
With over 961 company profiles, you can easily access detailed information to analyze the market, conduct competitive analysis, and qualify sales leads.
You can purchase our data directly through our self-service platform, or integrate it seamlessly into your systems via data APIs. Whether you need a one-time dataset or continuous access, Coresignal offers flexible solutions to meet your needs.
Coresignal is a public web data vendor that delivers fresh data about companies, professionals, and jobs for 500+ leading companies in market research, venture capital investment, HR tech, sales, and marketing industries. Founded in 2016, the company is known for its high-quality, fresh data and professional service. Coresignal is a member of the Ethical Web Data Collection Initiative and supports academic institutions with data for research.
in the market
clients
data records